Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 955 of 1,261

  1. US 7998736

    Adoptive immunotherapy with enhanced T lymphocyte survival

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  2. US 7998928

    Method of treatment of type-1 diabetes with a humanin analogue

    The Regents of the University of California · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  3. US 7994320

    Narcistatin prodrugs

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  4. US 7993648

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  5. US 7994313

    Unsolvated benzodiazepine compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  6. US 7994209

    3-phenoxymethylpyrrolidine compounds

    Theravance, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  7. US 7993919

    Method of inducing memory B cell development and terminal differentiation

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  8. US 7994360

    Benzofuran compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  9. US 7993921

    Cell cycle regulation and differentiation

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  10. US 7994139

    Antiviral therapeutic agents

    BioCryst Pharmaceuticals, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  11. US 7994143

    Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates

    The Regents of the University of California · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  12. US 7994150

    Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  13. US 7994174

    Pyridyl sulfonamides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  14. US 7994178

    Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  15. US 7994191

    Heterocyclic cyclopamine analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  16. US 7994183

    Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  17. US 7994193

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  18. US 7994226

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

    The Regents of the University of California · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  19. US 7994211

    Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses

    Argenta Discovery Limited · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  20. US 7994217

    Prenatal multivitamin/multimineral supplement

    Xanodyne Pharmaceuticals, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  21. US 7994272

    Maleamic acid polymer derivatives and their bioconjugates

    Nektar Therapeutics · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  22. US 7994309

    Compositions and methods for inhibiting expression of a mutant gene

    Alnylam Pharmaceuticals, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  23. US 7994306

    Methods of treating cancer using siRNA molecules directed against CD24

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  24. US 7994299

    Compositions and methods for increasing bone mineralization

    Darwin Discovery Limited · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.